Altering CAR Construct Design to Ameliorate CAR-T Cell Therapy Associated Cytokine Release Syndrome
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell | Nature Medicine
A safe and potent anti-CD19 CAR T cell therapy | Nature Medicine
A guide to manufacturing CAR T cell therapies - ScienceDirect
WO2017015427A1 - Methods for improving the efficacy and expansion of immune cells - Google Patents
Relationship between exposure and expansion of CTL019 cells and... | Download Scientific Diagram
Base-edited CAR T cells for combinational therapy against T cell malignancies | Leukemia
T Cell-Redirecting Strategies to 'STAb' Tumors: Beyond CARs and Bispecific Antibodies: Trends in Immunology
Clinical Development
Adnectin-Based Design of Chimeric Antigen Receptor for T Cell Engineering: Molecular Therapy
Antibodies | Free Full-Text | Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells
Optimization of CAR-T Cell-Based Therapies Using Small-Molecule-Based Safety Switches | Journal of Medicinal Chemistry
Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts | Journal for ImmunoTherapy of Cancer
The CD28-transmembrane domain mediates chimeric antigen receptor heterodimerization with CD28 | bioRxiv
Cancers | Free Full-Text | Engineering Solutions for Mitigation of Chimeric Antigen Receptor T-Cell Dysfunction
Clinical development of anti‐CD19 chimeric antigen receptor T‐cell therapy for B‐cell non‐Hodgkin lymphoma - Makita - 2017 - Cancer Science - Wiley Online Library
The long road to the first FDA-approved gene therapy: chimeric antigen receptor T cells targeting CD19 - Cytotherapy
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia | NEJM
Frontiers | The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia | NEJM
Cells | Free Full-Text | CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies
Application form Assessment of clinical research involving gene therapeutics in the Netherlands - Viral vectors
Quantitative Control of Gene-Engineered T-Cell Activity through the Covalent Attachment of Targeting Ligands to a Universal Immune Receptor | Journal of the American Chemical Society
The intrinsic potency of CAR T cells from patients with CLL drives... | Download Scientific Diagram
Driving Out Chronic Lymphocytic Leukemia With CAR T Cells - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia | NEJM
